Healthcare Industry News: Medix
News Release - October 17, 2006
Hydromedix Group, Inc. is Pleased to Announce the Appointment of Dr. Jeffery M. Bishop, D.O. as Vice President and Medical Director
WEST PALM BEACH, Fla.--(HSMN NewsFeed)--HydroMedix Group, Inc. (Pink Sheets:HMXG ) announced today that it has appointed Dr. Jeffery M. Bishop, D.O. as Vice President and Medical Director of our Company. His primary focus will include overseeing the many evolutionary phases of Prototype development and relationships to assist in "Real Patient Testing."As Chairman of the Board of Wellington Regional Medical Center and Vice Chief of Staff, Wellington Regional Medical Center, Dr. Bishop brings together extremely qualified individuals who bring a rich pastiche of successful medical experiences to bear for his new collaborative commitment and undertaking.
About Wellington Regional Medical Center: Wellington Regional Medical Center is located in Wellington, Florida. It is a 143 bed, acute care hospital, owned by a subsidiary of Universal Health Services, Inc., a highly respected, healthcare management organization. Wellington Regional is proud to provide the finest healthcare services to the Palm Beach County since 1986, as a community hospital, accredited by the Joint Commission on Accreditation of Healthcare Organizations.
Dr. Bishop's Professional Associations:
- National Board of Osteopathic Physicians and Surgeons; Diplomat
- Florida Academy of Osteopathy
- Florida Osteopathic Medical Association
- Florida Society of American College of General Practitioners
- American Osteopathic Association
- American Medical Association
- American College of General Practitioners in Osteopathic Medicine and Surgery
- Pennsylvania Osteopathic Society
- SIGMA - The Science Research Society
- American Academy of Sclerotherapy
- American Osteopathic Academy of Sports Medicine
About HydroMedix Group, Inc.
We are in the business of developing medical devices which accelerate the rate of healing of certain types of injuries, and, upon completion of development of the product and appropriate testing, we intend to market our product to a diverse market clientele, including medical offices, hospitals, long-term care facilities and physical therapists.
Our product is a safe and effective provider of hydrotherapy, a commonly used, medically accepted and known to be effective method by which water is used to treat muscle soreness. Our product provides the user with the therapeutic benefits of hydrotherapy without actually exposing the patient to water. In addition, our product may be used to provide icing, heat and whirlpool treatments in a manner which management believes provides the user with a greater degree of control and ease of use as compared to any of the traditional forms of hydrotherapy.
Water is an effective conductor of heat and is traditionally used to increase blood and lymphatic circulation. Our product can be used to combine the medical benefits of heat treatments with massage to stimulate the subject's muscle, leading to an increase in molecular motion in the skin which aids the healing process. Our product is particularly helpful when trying to use heat to treat localized areas of hyperirritability, or trigger points, in the muscles, to help ease any spasms and pains afflicting the patient. Our management believes that our product could also be used to effectively treat joint problems, such as tension and weakness in joints or a limited range of motion in joints.
HydroMedix may also be used for cold therapy, which helps reduce swelling by slowing the flow of blood and other fluids to an injured area. Cold therapy is routinely used for the treatment of sprains, strains and bruises as well as post-operative treatments such as retarding the formation of a hematoma.
- Plastic surgery post-operative recovery systems. Applications such as a facemask for providing gentle pressure, cooling or heat with the ability to receive a dry-whirlpool sensation helping to reduce swelling and speed recovery; a breast and torso application to assist with pain management from breast augmentation or reconstruction; and compression garments with temperature control and massage to reduce the post surgical complications from edema and swelling.
- Orthopedic Surgery, post-op treatment and Pain Management, also management of edema and swelling that will occur after any elective or traumatic procedure.
- Human healthcare. A mattress motion device designed to slow the onset of decubitus (bed) sores; and a wheelchair pad for quadriplegic patients to help control pressure sores.
- Sports injury rehabilitation. Appendage pieces for the treatment of body parts which are commonly injured by athletes, including the foot, ankle, knee, shoulder, elbow, hand and wrist.
- Veterinary equipment providing controllable icing or heating pressure and massage for use in treatment of equine legs, hoofs, back, shoulders and neck.
Our management believes that users of our products are likely to see an increase in circulation, mobility, tissue healing and overall relaxation with decreases in muscle spasms and metabolic toxins.
Forward-Looking Statements
Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as Hydromedix, Inc. "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe Hydromedix, Inc.'s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of Hydromedix, Inc., as appropriate, which could cause actual results to differ materially from those currently anticipated. Although Hydromedix, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and Hydromedix, Inc. do not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
Source: Hydromedix
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
